Through its acquisition of HanesBrands, Gildan Activewear (GIL) can now achieve the size and scale it couldn’t do on its own, ...
UBS' chief operations and technology officer, Mike Dargan, will leave the Swiss bank at the end of the month, the company ...
UBS announced changes on their executive board as Mike Dargan steps down from his post as the bank's Group Chief Operations ...
Mike Dargan, who starts in April, had served as the Swiss bank’s chief operations and technology officer. His hire ends a ...
UBS Group AG’s need for the highest-quality form of capital would drop to around $400 million if a compromise proposal on ...
A group of influential Swiss lawmakers proposed watering down the capital demands that the country wants to impose on UBS ...
UBS stock rises as Swiss lawmakers propose flexible capital rules, easing regulatory strain and boosting competitiveness.
Hingham Street Partners moved its team of 32, which booked $38.5M in annual revenue at UBS, to Wells Fargo’s Boston-based ...
TipRanks on MSN
Corcept Therapeutics initiated with a neutral at UBS
UBS analyst Ashwani Verma initiated coverage of Corcept Therapeutics (CORT) with a Neutral rating and $95 price target The firm cites valuation ...
In its fiscal Q4 2025 report, Analog Devices, Inc. (NASDAQ:ADI) showed solid growth. Revenue and earnings per share both came ...
Swiss lawmakers have floated a compromise on new capital rules for UBS to try to ensure it remains internationally ...
The stock rose to its highest point in 17 years, after legislators proposed reducing capital requirements on Swiss banks.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback